IMMX
Immix Biopharma·NASDAQ
--
--(--)
--
--(--)
4.87 / 10
Netural
Analyst sentiment is overwhelmingly bullish with a 100% strong-buy rating from one active analyst, though historical win rates are only 25%, indicating limited conviction. Money flow is favorable with a 7.72/10 score, reflecting positive inflows across most sizes, yet overall and block trends are negative, hinting at short-term profit-taking. Together, the analyst and fund-flow picture is neutral, underscoring the need for patience and vigilance.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-09
InstitutionHC Wainwright & Co.
Times predicted4
Historical Win Rate25.0%
Is money flowing into or out of IMMX?
- IMMX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.87/10 (Netural).
